Tempest Therapeutics, Inc.
USD1.31
-0.14 (-9.66%)
CEO
Matthew Angel
IPO Date
2012-11-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.43
Prev. Close
$1.45
Day Low
$1.29
Day High
$1.43
52W Low
$1.29
52W High
$12.23
Market Cap
$0.01B
Volume
0.26M
| 140,000 |
| $1.64 |
| 25 Mar 2026 | Angel Matthew | director, 10 percent owner, officer: CEO and President | P-Purchase | Acquired | 231,482 | $2.16 |
| 6 Feb 2026 | Angel Matthew | director, 10 percent owner, officer: CEO and President | A-Award | Acquired | 269,621 | $2.38 |
| 6 Feb 2026 | Angel Matthew | director, 10 percent owner, officer: CEO and President | Disposed | 0 | $0.00 |
| 28 Jan 2026 | Simantov Ronit | director | A-Award | Acquired | 1,230 | $2.94 |
| 28 Jan 2026 | NICHOL GEOFFREY | director | A-Award | Acquired | 1,230 | $2.94 |
| 28 Jan 2026 | RAAB MICHAEL | director | A-Award | Acquired | 1,230 | $2.94 |
| 28 Jan 2026 | Pellizzari Christine A | director | A-Award | Acquired | 1,230 | $2.94 |
| 12 Aug 2024 | Versant Venture Capital VI, L.P. | 10 percent owner | S-Sale | Disposed | 400,000 | $1.35 |